bibliographic entry 6949533 [be/6949533]
https://w3id.org/oc/corpus/be/6949533

is a
content
  • Yang HK, Min KW, Park SW, et al. A randomized, placebo-controlled, double-blind, phase 3 trial to evaluate the efficacy and safety of anagliptin in drug-naïve patients with type 2 diabetes. Endocr J 2015; 62:449-62. doi:10.1507/endocrj.EJ14-0544. 25819061.
references